全文获取类型
收费全文 | 20640篇 |
免费 | 1625篇 |
国内免费 | 694篇 |
专业分类
耳鼻咽喉 | 111篇 |
儿科学 | 494篇 |
妇产科学 | 254篇 |
基础医学 | 2124篇 |
口腔科学 | 262篇 |
临床医学 | 1917篇 |
内科学 | 2332篇 |
皮肤病学 | 227篇 |
神经病学 | 1264篇 |
特种医学 | 917篇 |
外国民族医学 | 1篇 |
外科学 | 1529篇 |
综合类 | 3142篇 |
现状与发展 | 1篇 |
预防医学 | 2091篇 |
眼科学 | 405篇 |
药学 | 2649篇 |
10篇 | |
中国医学 | 2054篇 |
肿瘤学 | 1175篇 |
出版年
2024年 | 64篇 |
2023年 | 264篇 |
2022年 | 627篇 |
2021年 | 853篇 |
2020年 | 656篇 |
2019年 | 558篇 |
2018年 | 564篇 |
2017年 | 687篇 |
2016年 | 800篇 |
2015年 | 796篇 |
2014年 | 1416篇 |
2013年 | 1628篇 |
2012年 | 1339篇 |
2011年 | 1499篇 |
2010年 | 1222篇 |
2009年 | 1033篇 |
2008年 | 1011篇 |
2007年 | 940篇 |
2006年 | 910篇 |
2005年 | 806篇 |
2004年 | 700篇 |
2003年 | 619篇 |
2002年 | 485篇 |
2001年 | 441篇 |
2000年 | 362篇 |
1999年 | 279篇 |
1998年 | 246篇 |
1997年 | 236篇 |
1996年 | 226篇 |
1995年 | 183篇 |
1994年 | 173篇 |
1993年 | 134篇 |
1992年 | 149篇 |
1991年 | 121篇 |
1990年 | 103篇 |
1989年 | 93篇 |
1988年 | 90篇 |
1987年 | 76篇 |
1986年 | 63篇 |
1985年 | 82篇 |
1984年 | 73篇 |
1983年 | 66篇 |
1982年 | 48篇 |
1981年 | 54篇 |
1980年 | 47篇 |
1979年 | 40篇 |
1978年 | 23篇 |
1977年 | 19篇 |
1976年 | 17篇 |
1974年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Age, hematopoietic growth factors, cyclosporin A, mode of bone marrow transplantation (BMT) (autologous, allogeneic-related,
unrelated), and underlying disease were assessed as potential risk factors for capillary leakage syndrome (CLS) in 96 patients
after BMT. CLS was defined as unexplained weight gain of >3% within 24 h and nonresponsiveness to furosemide. CLS occurred
in 9/21 patients after unrelated compared with 2/33 after allogeneic-related BMT (p=0.0017) for hematopoietic disorders (n=54) and in 6/7 patients after allogeneic-related compared with 3/35 after autologous BMT (p=0.0001) for solid tumors (n=42). Hematopoietic growth factors and cyclosporin A were no signficant risk factors on their own. We conclude that unrelated
BMTs or high-intensity conditioning regimens used in combination with allogeneic-related BMT are the main risk factors for
CLS.
Received: 6 January 1997 / Accepted: 10 March 1997 相似文献
52.
Bronchial hyperresponsiveness (BHR) and damage of the epithelium, as well as eosinophilia in the airway wall, induced by trimellitic anhydride (TMA) in sensitized brown Norway rats were studied. Rats were challenged once or seven times with aerosol of TMA conjugated to rat serum albumin (TMA-RSA) 3 weeks after intradermal TMA sensitization. Airway responsiveness (-log PC300 of acetylcholine i.v.) was measured 24 h after allergen challenge. Epithelial lesion and eosinophil infiltration in the airway walls were quantified under light microscopy, and TMA-specific IgE and IgG in serum were evaluated with ELISA. High levels of TMA-specific IgE and IgG were found in all rats in the sensitized groups compared to nonsensitized groups ( P < 0.001). Repeated allergen challenges of 0.03% TMA-RSA for 7 consecutive days enhanced the level of TMA-specific IgG, compared to single challenge ( P < 0.05). Single allergen challenge of 0.3% TMA-RSA had a nonsignificant tendency to produce BHR in sensitized rats compared to nonsensitized rats ( P =0.06). However, repeated allergen challenges (0.003% and 0.03% TMA-RSA for 7 consecutive days) produced significant BHR in sensitized rats ( P < 0.05). Furthermore, repeated low-dose (0.003%) TMA-RSA challenge produced more BHR than a 10 times higher single dose (0.03%) ( P < 0.05). Slight damage of the airway epithelium was seen in sensitized and repeat-challenged groups. However, bronchial eosinophilia was found in the sensitized and single-challenged groups, but not in nonsensitized nonchallenged, and sensitized repeat-challenged groups ( P < 0.005). We conclude that the brown Norway rat can be sensitized with TMA, and that repeated low-dose allergen challenges produce slight epithelial damage and BHR which is independent of ongoing eosinophilia in the airway wall. 相似文献
53.
We have previously established a cell damage model, with damage induced by either acid or pepsin treatment for 30 min, involving a rat gastric epithelial cell line (RGM1). In the present study, pretreatment of cells with epidermal growth factor (EGF; 0.1–10ng/mL) or sucralfate (0.1–3 mg/mL) for 4 h prevented such cell damage in a concentration-dependent manner. Protection of cells by these drugs was not affected by pretreatment with indomethacin (10−5 mol/L) for 4 h. Removal of Na− , but not Ca2+ , from the acidified medium totally abolished the inhibitory effect of EGF, but not that of sucralfate. Genistein (a tyrosine kinase inhibitor) apparently reduced the inhibitory effect of EGF. DNA synthesis by RGM1 cells did not increase when cells were incubated with EGF for 4 h. We conclude that both EGF and sucralfate protect RGM1 cells from acid- and pepsin-induced damage and that the mechanism of protection by EGF against acid-induced damage seems to be via activation of Na+ /H+ exchangers. 相似文献
54.
55.
Shiro Saito Makoto Hata Ryuichi Fukuyama Kosuke Sakai Jun Kudoh Hiroshi Tazaki Nobuyoshi Shimizu 《International journal of urology》1997,4(2):178-185
Background Mutation converts the H-ras gene into an activated oncogene in about 10% of human bladder cancers. Codons 12 and 61 are the major "hot spots" for activation. A simple and accurate method to detect point mutations in these codons may be clinically useful for early diagnosis of bladder cancer.
Methods Bladder cancer samples from 50 patients, plus 10 samples of normal bladder mucosa, were analyzed for possible point mutation of the H-ras gene at either codon 12 or codon 61. The H-ras gene DNA segments that include these 2 codons were amplified by PCR methods, then the possible presence of a point mutation was evaluated at each codon by susceptibility of the respective DNA segments to digestion with the restriction enzyme and by dot blot hybridization assay. A bladder cancer patient who had an H-ras gene mutation was examined to see whether the mutation was also detectable in the cells released in the urine.
Results Definite or possible point mutations were found in 6 (1 2%) out of 50 bladder cancer patients, while no mutation was detected in normal mucosa. A point mutation could also be detected in cells isolated from the patient's urine sample.
Conclusion The prevalence of point mutations at codon 1 2 or codon 61 of the H-ras gene found in this study was similar to that previously estimated for human bladder cancer by DNA transfection assay. The method we have used for detecting point mutations of the H-ras gene provides a simple and highly accurate way to detect mutated cancer cells even in the urine. It may be clinically usable for early diagnosis of bladder cancer. 相似文献
Methods Bladder cancer samples from 50 patients, plus 10 samples of normal bladder mucosa, were analyzed for possible point mutation of the H-ras gene at either codon 12 or codon 61. The H-ras gene DNA segments that include these 2 codons were amplified by PCR methods, then the possible presence of a point mutation was evaluated at each codon by susceptibility of the respective DNA segments to digestion with the restriction enzyme and by dot blot hybridization assay. A bladder cancer patient who had an H-ras gene mutation was examined to see whether the mutation was also detectable in the cells released in the urine.
Results Definite or possible point mutations were found in 6 (1 2%) out of 50 bladder cancer patients, while no mutation was detected in normal mucosa. A point mutation could also be detected in cells isolated from the patient's urine sample.
Conclusion The prevalence of point mutations at codon 1 2 or codon 61 of the H-ras gene found in this study was similar to that previously estimated for human bladder cancer by DNA transfection assay. The method we have used for detecting point mutations of the H-ras gene provides a simple and highly accurate way to detect mutated cancer cells even in the urine. It may be clinically usable for early diagnosis of bladder cancer. 相似文献
56.
小柴胡汤口服液药效作用的研究 总被引:2,自引:0,他引:2
观察了小柴胡汤口服液的主要药理作用。研究表明,小柴胡汤口服液有显著抑制角叉菜胶诱发的大鼠踝关节水肿(p<0.05),保护四氯化碳所致的大鼠急性肝功能损害,有极显著降低血清SGPT及LDH的作用(P<0.01)。对家兔发热反应也有较好的抑制作用。此外,小柴胡汤口服液对小鼠兔疫反应也有一定的增强作用,可促进小鼠碳粒廓清速率,提高血清溶血素水平及增强鸡红细胞所致的迟发性过敏反应。 相似文献
57.
化疗对淋巴瘤伴乙肝病毒感染患者肝功能影响的回顾性分析 总被引:1,自引:0,他引:1
目的研究化疗对淋巴瘤伴乙肝病毒感染患者肝功能的影响。方法回顾性病例分析,比较50例HBsAg(-)、20例HBsAg(+)和18例小三阳的恶性淋巴瘤患者化疗后肝功能变化情况。结果HBsAg(-)组、HBsAg(+)组和小三阳组化疗后Ⅲ级以上肝功能损害分别是0%、15%、55%。结论伴乙肝病毒感染的淋巴瘤患者化疗后肝功能损害明显,尤其小三阳患者损害更为严重,甚至死亡。 相似文献
58.
Yu. B. Lishmanov L. N. Maslov N. V. Naryzhnaya 《Bulletin of experimental biology and medicine》1997,123(3):239-241
Immobilization induces stress damage to the heart. DAGO, an agonist of μ-opiate receptors potentiates, while an agonist of
peripheral μ-opiate receptors prevents this damage. Naltrexone reduces, while methylnaltrexone, an inhibitor of peripheral
μ-opiate receptors, potentiates the stress-induced damage to the heart. Other opiate ligands have no effect on heart damage.
It is suggested that the stress-induced damage to the heart is promoted by activation of central μ-opiate receptors and prevented
by stimulation of peripheral μ-opiate receptors.
Translated fromByulleten'Eksperimental'noi Biologii i Meditsiny, Vol. 123, No. 3, pp. 276–278, March, 1997 相似文献
59.
Summary: The origins of human mesial temporal lobe epilepsy and hippocampal sclerosis are still not well understood. Hippocampal sclerosis and temporal lobe epileptogenesis involve a series of pathologies including hippocampal neuronal loss and gliosis, axonal reorganization, and maybe hippocampal neoneurogenesis. However, the causality of these events is unclear as well as their relation to the factors that may precipitate epileptogenesis. Significant differences between temporal lobe epileptogenesis in the adult and immature brain may require differential approaches. Hereditary factors also may participate in some cases of hippocampal sclerosis. The key point is to identify the significance of these age-dependent changes and to design preventive treatments. Novel strategies for the prevention and treatment of mesial temporal lobe epilepsy and hippocampal sclerosis may include rational use of neuroprotective agents, hormonotherapy, immunizations, and immunotherapy. 相似文献
60.
肝钳与肝门阻断的肝损害及其防治的实验研究 总被引:2,自引:0,他引:2
本实验观察不同阻断时刻肝钳与肝门阻断的肝损害以及预防性应用抗氧化剂的缓解作用。结果表明:(1)SGPT、TB在肝钳组的变化比肝门阻断组表现得更为一过性。而肝门阻断给药组的改变要比非给药组的轻微且恢复得快。(2)肝门阻断时,MDA含量显著升高,机体的T-AOC和SOD下降。而给药组可明显减轻上述改变。(3)随着肝门阻断时间的延长,肝组织损害也相应加重,抗氧化剂的给予缓解了肝缺血和再灌注造成的组织损害。肝钳组由于健肝血供未受干扰,因此,不同阻断时刻肝组织学形态与对照组相似无甚改变。结论:(1)肝钳较肝门阻断的肝损害轻,且实用安全。(2)肝门阻断预防性使用抗氧化剂,可明显减轻肝缺血再灌注损害。(3)肝门阻断时经门静脉较外周静脉输注抗氧化剂,其保护作用更直接、明显 相似文献